冠心康颗粒治疗冠心病稳定性心绞痛49例临床观察  

Clinical Observation on Guanxinkang Granule in Treating 49 Cases of Coronary Stable Angina Cordis

作　　者：卞继芳[1] 王清海[1] 黄琳[1] 李桂明[1] 李典鸿[1] 梁宏宇[1] 

机构地区：[1]广东省第二中医院,广东广州510095

出　　处：《河南中医》2005年第7期30-32,共3页Henan Traditional Chinese Medicine

基　　金：国家中医药管理局重点科研基金(编号:97L009)

摘　　要：目的观察冠心康颗粒治疗冠心病稳定性心绞痛的临床疗效。方法采用随机对照试验方法观察冠心康颗粒治疗冠心病稳定性心绞痛49例,与复方丹参片对照组比较疗效。结果治疗组和对照组的有效率分别为92.79%和94.8%(P>0.05)。冠心病稳定性心绞痛症状的显效率和有效率分别为52.2%、41.4%和41.5%、52.6%(P>0.05)。心电图的显效率和有效率分别为36.0%、28.0%和15.8%、5.3%(P<0.01)。结论冠心康颗粒疗效明显优于复方丹参片。在安全性方面,两者都未发现明显的不良反应和毒副作用。Objective: To observe the therapeutic effect of Guanxinkang Granule in treating coronary stable angina cordis. Methods: The therapeutic effect of Guanxinkang Guanule in treating 49 cases of coronary stable angina cordis was observed with the method of random contrast experiment, compared with that of the controlled group by Compound Danshen Tablets. Results: The treated group and the controlled group have respective effective rats: 92.79% and 94.8%(P>0.05). Two groups have the respective effectual rates and effective rates for syndromes of coronary stable angina cordis: 52.2%, 41.4% and 41.5%, 52.6%(P>0.05). Two groups have the respective effectual rates and effective rates of electrocardiogram: 36.0%, 28.0% and 15.8%, 5.3%(P<0.01). Conclusion: The results indicate that Kuanxinkang Granule is superior to Compound Danshen Tablets in the therapeutic effect. And in the respect of safety, both show no obvious side effects and toxic effects.

关 键 词：冠心病稳定性心绞痛 冠心康颗粒 复方丹参片 

分 类 号：R541.4[医药卫生—心血管疾病]